Antimicorbial treatment of Acinetobacter baumannii pneumonia
WANG Fei
HE Bei
Abstract：Hospital-acquired pneumonia (HAP) caused by Acinetobacter baumannii (AB) should be highly concerned. In recent years, the drug resistant rate of AB has increased year by year. It has been confirmed that the mortality of HAP caused by multidrug-resistant AB or even extensively drug-resistant AB is relatively high, so the selection of antibiotics is a great challenge in clinical practice. At present, AB is only sensitive to polymyxin and tigecycline, and is resistant to most of the other antibiotics including sulbactam, carbapenem, quinolone and aminoglycoside. However, the sensitivity to the antibiotics can be improved by increasing dose, prolonging infusion time, or combining other antibiotics, so as to improve the curative rate.
Keywords：Acinetobacter baumanniidrug tolerancepneumonia
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 189-192 )